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Abstract 
The most common neurological manifesta-
tion of Cryptococcus neoformans infection is
meningitis.  Other  less  common  manifesta-
tions include parenchymal central nervous sys-
tem  (CNS)  granulomatous  disease,  hydro-
cephalus and stroke. C. neoformans is often
suspected in immunodepressed patients, but it
can be easily overlooked in otherwise healthy
patients. This paper provides a detailed clinical
description  of  a  patient  without  immunosu-
pression who developed multiple simultaneous
neurological manifestations after the infection
with C. neoformans.
Case Report
A 52-year old woman presented to the emer-
gency  department  with  acute  headache  that
began  seven  days  before  her  arrival.  Her
headache  had  been  severe  since  onset,
increased when lying supine or performing the
Valsalva maneuver and improved slightly upon
standing. She also had frequent episodes of
projectile  vomiting  and  neck  stiffness.  Her
medical  history  was  otherwise  normal.  She
was not under corticosteroid or immunosup-
pressive  treatments,  nor  undergoing  chemo-
therapy or radiotherapy. She lived on a farm
and had daily contact with hens and other farm
animals. 
The neurological examination was remark-
able  for  bilateral  papilledema,  photophobia,
and nucal rigidity. Peripheral leukocyte count
was 8.4 cells/mm
3. The rest of the laboratory
parameters were non-revealing, including two
negative HIV serologies and one negative HIV
viral load. Laboratory tests failed to reveal the
existence of other immunological deficits. A
PPD skin test was negative. A brain computer-
ized tomography (CT) showed marked dilata-
tion of the lateral and third ventricles and a
hypodense lesion in the right caudate nucleus.
Cerebro spinal FwID (CSF) analysis revealed
89  leukocytes/μL  (92%  monocytes,  8%  poly-
morphonucleates (PMN), increased total pro-
teins of 81 mg/dL, glucose of 44 mg/dL (corre-
sponding blood glucose 116 mg/dL), and two
positive latex agglutination tests for cyptococ-
cal  antigen.  CSF  polymerase  chain  reaction
(PCR)  for  tuberculosis  was  negative.
Additional CSF testing also included negative
herpes simple virus, herpes zoster virus and
Ebstein-Barr virus PCR, and negative bacteri-
al,  viral  and  acid-fast  bacillus  cultures.
Treatment with amphotericin B was initiated
and the headache improved dramatically. Two
days later, a brain magnetic resonance imag-
ing (MRI) showed hydrocephalus, an infarct in
the  right  caudate  nucleus  (Figure  1)  and
marked  gadolinium  enhancement  of  the
arachnoideal meninges and surrounding the
vessels (Figure 2) at the basilar region. A small
meningeal collection adjacent to the clivus was
also noted (Figure 2). The MRA was normal. A
transcranial Doppler ultrasound showed asym-
metric  blood  flow  suggestive  of  small  vessel
vasculopathy. Dexametasone was added to pre-
vent further infarcts. A lumbar puncture after
three  weeks  of  treatment  showed  50  leuko-
cytes/μL (71% monocytes, 29% PMN), proteins
36 mg/dL, and glucose 54 mg/dL (correspond-
ing  blood  glucose  96  mg/dL).  Symptoms
resolved completely and the patient was dis-
charged  after  three  weeks  with  fluconazole
and prednisone without neurological sequelae.
Discussion
C. neoformans is a free-living fungus found
throughout the world, often isolated from soil
associated with avian excreta. CNS infection
may occur rarely in immunocompetent hosts.
1-4
Before the HAART era, the incidence of CNS C.
neoformans infection  in  immunocompetent
hosts was estimated to be 0.8 cases per million
persons per year.
1 Possibly 10-40% of HIV-neg-
ative patients with cryptococcosis, do not have
a known immune disorder.
5
Without  prompt  diagnosis,  cryptococcal
infections  of  the  nervous  system  can  cause
severe  neurological  disability  and  death.
Immunocompetent hosts usually show a more
acute onset of signs and symptoms, less posi-
tive India ink stains, lower titers of CSF anti-
gen (less than 1:1024), higher CSF host cells,
less  cryptococcemia  or  extracranial  sites
involved, less parenchymal brain lesions, and
lower intracranial pressure when compared to
HIV-positive patients.
1-5 CSF latex antigen cryp-
tococcal agglutination test has a high sensitiv-
ity of 92% in CSF.
1 In seronegative patients the
polysaccharide antigen test may be the only
positive test in earlier infections.
5
The optimal duration of treatment for non-
AIDS patients remains uncertain. For other-
wise healthy hosts with CNS disease, ampho-
tericin B plus flucytosine for 6-10 weeks is rec-
ommended.
5 An alternative to this regimen is
amphotericin B plus flucytosine for two weeks,
followed by fluconazole for a minimum of ten
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Figure 2. T1 Sagital MRI with gadolinium
showing  ventricular  dilatation,  basal
arachnoiditis,  (thick  arrow)  perivascular
enhancement (thin arrow) and a dural col-
lection dorsal to the clivus (arrow heads).
Figure  1.  T1  Axial  MRI  showing  severe
dilatation of the lateral and third ventricles
and a lesion in the region of the right cau-
date nucleus.weeks.
6 The relapse rate in immunocompetent
patients is estimated at 15-25%. Maintenance
therapy with fluconazole is not warranted, and
antifungal  drug  therapy  must  be  individual-
ized.  Although  the  use  of  steroids  is  not
described in vasculopathy associated with C.
neoformans,  steroids  have  shown  greater
improvement  or  stabilization  in  other  infec-
tious vasculopathies. 
Conclusions
Cryptococcus neoformans infection is rarely
suspected in non-HIV patients. This produces a
considerable diagnostic delay and worsens the
prognosis in otherwise healthy patients.
7 As in
this case, intracranial hypertension and basi-
lar meningitis due to CNS cryptococcosis are
the most common manifestations. Less com-
mon complications include communicating or
non-communicating  hydrocephalus,  subdural
collections and stroke due to vasculitis. The
diagnosis of CNS cryptococcosis can be rapidly
achieved by detection of cryptococcal antigen
titers  in  the  CSF.  The  length  of  antifungal
treatment and the determination of the opti-
mal dose, duration and benefit of steroid ther-
apy in associated vasculopathy await studies
with larger case numbers.
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